February 19, 2026
Proposed Local Coverage Determinations (LCDs) Released for Comment – Power Mobility Devices and Wheelchair Options/Accessories
Joint DME MAC Publication
The Centers for Medicare and Medicaid Services (CMS) assigned to the Durable Medical Equipment Medicare Administrative Contractors (DME MACs) the task of developing LCDs for Durable Medical Equipment, Prostheses, Orthoses, and Supplies (DMEPOS). The DME MACs are proposing two LCDs as described below:
Power Mobility Devices (DL33789): Proposing a not reasonable and necessary determination for Group 2 power wheelchairs (PWCs) with seat elevation systems (K0830 and K0831), based on the best available evidence. Per the National Coverage Determination (NCD) 280.16 Seat Elevation Equipment (Power Operated) on Power Wheelchairs, coverage of Group 2 PWCs with seat elevators would be determined at the MAC's discretion.
Wheelchair Options/Accessories (DL33792): Proposing a not reasonable and necessary determination for the use of seat elevation added onto non-complex power wheelchairs, based on the best available evidence. The proposed LCD proposes to include, in the coverage criteria for power tilt and/or recline seating systems, examples of clinical conditions that limit the beneficiary's ability to perform a functional weight shift. Per National Coverage Determination (NCD) 280.16 Seat Elevation Equipment (Power Operated) on Power Wheelchairs, coverage of power seat elevation equipment for individuals who use Medicare-covered power wheelchairs other than complex rehabilitative power-driven wheelchairs would be determined at the MAC's discretion.
Stakeholders may read the details of each proposed LCD posted on the Medicare Coverage Database by referencing the LCD ID number in the search field. The entire proposed LCD(s) should be reviewed prior to the submission of written comments.
We are soliciting comments on the proposed LCDs from stakeholders (including, but not limited to, clinicians, manufacturers, suppliers, and other parties who care for Medicare beneficiaries). You should be very specific in your comments and, if possible, offer suggestions that may address your concerns. You should provide an evidence-based rationale for your comments and attach any full-text references from the published clinical literature (for example, peer-reviewed journals, clinical society guidelines, etc.) that were not included in the bibliography of the proposed LCD. We encourage a written response regardless of your agreement or disagreement with the proposed LCD.
In your comments, please be sure to disclose all conflicts of interest you have with any manufacturer(s) or supplier(s) of the DMEPOS items addressed in the proposed LCD.
All comments will be collected at a single point of contact for each proposed LCD. Comments that address more than one proposed LCD must be submitted to each LCD email address for which comments are being made. Do not include any protected health information (PHI) or personally identifiable information (PII). Submit your comments electronically to the DME MACs at the applicable email address(es) listed below no later than Saturday, April 4, 2026.
Power Mobility Devices (DL33789): PMDRecon@noridian.com
Wheelchair Options/Accessories (DL33792): WCOARecon@noridian.com
Response to comments will only be provided in the policy's Response to Comments article if the comments are sent to the proposed policy's designated email address. If commenters want to address both proposed LCDs, they may send a single email that includes both email addresses.
If the proposed LCD coverage criteria refer to an LCD-related Policy Article (PA), then a convenience copy of a draft PA document may be attached to the proposed LCD. A draft PA document attached to a proposed LCD is only provided for reference purposes.
Suppliers and clinicians are cautioned not to make any changes based upon information contained in a proposed LCD. The content of a proposed LCD may be revised based upon the written comments received during the comment period. When all written comments have been reviewed, revisions will be considered.
IMPORTANT: The DME MACs will host virtual open meetings to further solicit input from stakeholders for the proposed LCDs. The virtual meetings will take place on March 25, 2026. For details regarding participation in the virtual open meetings, refer to the open meeting announcement article posted at Open Meeting Announcement – Power Mobility Devices and Wheelchair Options/Accessories Proposed Local Coverage Determinations (LCDs).
Refer to each DME MAC website for additional information, including access to the proposed LCDs.
Thank you for your participation in our policy development process.
| Smitha M. Ballyamanda, MD, CAQSM Medical Director, DME MAC Jurisdiction A Noridian Healthcare Solutions, LLC |
Robert D. Hoover, Jr., MD, MPH, FACP Medical Director, DME MAC Jurisdiction C CGS Administrators, LLC |
| Sunil V. Lalla, MD, FACS, CPC Medical Director, DME MAC Jurisdiction B CGS Administrators, LLC |
Angela S. Jenny, DO, DABFM Medical Director, DME MAC, Jurisdiction D Noridian Healthcare Solutions, LLC |

